ReviewCureus2022
A Narrative Review of Vitamin A Supplementation in Preterm and Term Infants.
Review in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Enteral vitamin a supplementation for the prevention of bronchopulmonary dysplasia in preterm infants: an updated systematic review and meta-analysis.Annals of medicine and surgery (2012) · 2025Article
- Oxygen in the neonatal ICU: a complicated history and where are we now?Frontiers in pediatrics · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vitamin A deficiency is an epidemiologically significant concern in all age groups, especially in preterm and term infants. Its deficiency causes various developmental malformations. Vitamin A supplementation has been a practiced alternative for many decades, but its effectiveness is debatable in the medical system. The bioavailability of beta-carotenes varies greatly and ranges from 2% to 30%, depending on how it is present in the plant's cellular composition. Vitamin A has a bioavailability of up to 75%. The bioavailability of beta-carotenes is positively impacted by several activities but mainly by mechanical ones that allow cellular interaction. These include enough chewing, mincing, and pureeing. The bioavailability of beta-carotene can be increased by moderate cooking and combining high-quality lipids. The WHO recommends waiting for a minimum of one month between vitamin A dosages. Six months is the maximum amount of time between dosages. For instance, giving the optimum dosage to a child who has not had vitamin A in two months is preferable to skipping the dose and making the child wait eight months (i.e., two months plus six months) before receiving the following amount. There were no discernible variations in the occurrence of momentarily increased aspartate aminotransferase (AST), alanine transaminase (ALT), or alkaline phosphatase between the leading group and the trace group. However, patients in the top group experienced high blood triacylglycerol levels more frequently than those in the trace group, suggesting that hypertriacylglycerolemia may be a side effect of vitamin A administration. It is imperative to memo that neonatal vitamin A supplementation negatively affects subsequent diphtheria-pertussis-tetanus (DPT) vaccination in females. Since many children are delayed in obtaining their initial DPT series, several nations prescribe DPT boosters, so older children may be affected if vitamin A supplementation negatively interacts with DPT in such children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.